SR BIOTEK INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,100 KRW | +3.16% |
|
+2.82% | -13.53% |
| 2022 | SR biotek Inc. announced that it has received KRW 443.8467 million in funding | CI |
| 2022 | SR biotek Inc. announced that it expects to receive KRW 443.8467 million in funding | CI |
More news
| 1 day | +3.16% | ||
| 1 week | +2.82% | ||
| Current month | -8.82% | ||
| 1 month | -8.82% | ||
| 3 months | -3.12% | ||
| 6 months | -25.30% | ||
| Current year | -13.53% |
1 week
3 000.00
3 195.00
1 month
2 670.003 585.00
Current year
2 670.003 590.00
1 year
2 670.006 580.00
3 years
2 510.008 430.00
5 years
2 510.0020 300.00
10 years
2 510.0033 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Byung-Ho Song
CEO | Chief Executive Officer | 60 | - |
So-Hyung Lee
CEO | Chief Executive Officer | 41 | - |
Su-Jin Jeong
BRD | Director/Board Member | 51 | 24/20/24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
So-Hyung Lee
CEO | Chief Executive Officer | 41 | - |
Hyun-Seok Park
BRD | Director/Board Member | 37 | 24/20/24 |
Byung-Ho Song
CEO | Chief Executive Officer | 60 | - |
SR biotek Inc. is a Korea-based company principally engaged in the manufacture and distribution of cosmetics. The Company distributes its products under brand name RAPHITOX and IDENEL LINE. The Company distributes its products within domestic market and to overseas markets.
Sector
Personal Products
| 1st Jan change | Capi. | |
|---|---|---|
| -13.53% | 2.87M | |
| +12.14% | 18.94B | |
| 0.00% | 17.84B | |
| -0.47% | 10.7B | |
| -7.25% | 10.31B | |
| +7.52% | 6.95B | |
| +10.34% | 5.98B | |
| -0.06% | 4.56B | |
| -18.21% | 3.77B | |
| -3.97% | 3.58B |
- Stock Market
- Equities
- A270210 Stock
